Quality of life in patients with severe left ventricle dysfunction due to coronary artery disease

• Autorzy: Damian Kawecki , Grzegorz Kubiak , Katarzyna Orszulik , Aleksandra Kusińska , Katarzyna Mitręga , Magdalena Pałka , Zofia Trzepaczyńska , Ewa Nowalany-Kozielska
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

Severe left ventricle dysfunction; Revascularization; Quality of life

• Czasopismo: Open Medicine
• Rocznik: 2011
• Tom: 6
• Numer: 6
• Strony: 807-812

Daty

wydano

2011-12-01

online

2011-10-08

Twórcy

autor

Damian Kawecki

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland,

autor

Grzegorz Kubiak

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

autor

Katarzyna Orszulik

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

autor

Aleksandra Kusińska

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

autor

Katarzyna Mitręga

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

autor

Magdalena Pałka

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

autor

Zofia Trzepaczyńska

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

autor

Ewa Nowalany-Kozielska

• 2nd Department of Cardiology, Medical University of Silesia, 10, Marie Curie-Skłodowska Street, 41-800, Zabrze, Poland

Bibliografia

• [1] Patrick W. Serruys, Marie-Claude Morice, A. Pieter Kappetein,et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. NEJM 2009; Vol. 360:961–972 http://dx.doi.org/10.1056/NEJMoa0804626[Crossref]
• [2] Aamir Javaid, Daniel H. Steinberg, Ashesh N. Buch, et al. Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease. Circulation. 2007;116:I-200–I-206 http://dx.doi.org/10.1161/CIRCULATIONAHA.106.681148[Crossref]
• [3] Stuart N. Hoffman, John A. TenBrook Jr, Michael P. Wolf, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. JACC 2003; Vol.41, No.8: 1293–1304
• [4] Franciosa JA, Wilen M, Ziesche S, et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831–836 http://dx.doi.org/10.1016/S0002-9149(83)80141-6[Crossref]
• [5] Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). Circulation 1981;63:793–802 http://dx.doi.org/10.1161/01.CIR.63.4.793[Crossref]
• [6] Moussa I, Reimers B, Moses J, et al. Long-term angiographic and clinical outcome of patients undergoing multi-vessel coronary stenting. Circulation 1997;96:3873–3879
• [7] Sak Lee, Byung-Chul Chang, Kyung-Jong Yoo, et al. Clinical Results of Coronary Revascularization In Left Ventricular Dysfunction. Circulation Journal 2007; 71: 1862–1866 http://dx.doi.org/10.1253/circj.71.1862[Crossref]
• [8] RITA Trials Participants. Coronary angioplasty versus coronary artery bypass surgery: The Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573–580 http://dx.doi.org/10.1016/0140-6736(93)90348-K[Crossref]
• [9] Hueb W, Soares PR, Gersh BJ, et al. The Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multi-vessel coronary artery disease: 1-year results. J Am Coll Cardiol 2004;43:1743–1751 http://dx.doi.org/10.1016/j.jacc.2003.08.065[Crossref]
• [10] The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336:525–533 http://dx.doi.org/10.1056/NEJM199702203360801[Crossref]
• [11] Badhwar V, Bolling SF. Nontransplant surgical options for heart failure. In: Cohn LH, Edmunds LH Jr. Editors. Cardiac surgery in the adult. New York: McGraw-Hill; 2003; 1515–1526
• [12] Marwick TH, Zuchowski C, Lauer MS, et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750–758 http://dx.doi.org/10.1016/S0735-1097(98)00642-1[Crossref]
• [13] Dilip D, Rao MH, Chandra A, et al. Coronary artery bypass in patients with severe left ventricular dysfunction. Asian Cardiovascular Thoracic Ann 2002 Sep;10(3):211–214
• [14] Anonymous. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with mulivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI). JAMA 1997;277:715–721
• [15] Pocock SJ, Henderson RA, Seed P, et al. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation 1996;94:135–142
• [16] Buszman P, Szkróbka I, Gruszka A, et al. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. Am J Cardiol. 2007 Jan 1;99(1):36–41 http://dx.doi.org/10.1016/j.amjcard.2006.07.056[Crossref]
• [17] O’Connor CM, Velazquez EJ, Gardner LH, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002 Jul 15;90(2):101–107 http://dx.doi.org/10.1016/S0002-9149(02)02429-3[Crossref]
• [18] Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the medicine, angioplasty, Or surgery study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007;115:1082–1089 http://dx.doi.org/10.1161/CIRCULATIONAHA.106.625475[Crossref][WoS]
• [19] Malenka DJ, Leavitt BJ, Hearne MJ et al. Comparison long-term survival of patients with multivessel coronary disease after CABG or PCI. Analysis of BARI-Like patients in Northern New England. Circulation 2005;112[suppl I]:I-371–I-376

Identyfikatory

DOI

10.2478/s11536-011-0095-0